Skip to main content
Explore URMC
menu

UMLT18037 / Mayo MC17C1 / Richard Dunne

Research Question:
What are the side effects of ketoconazole and how well it works in treating participants with ongoing EGFR inhibitor-induced rash?

Basic Study Information

Purpose:
This early phase I trial studies the side effects of ketoconazole and how well it works in treating participants with ongoing EGFR inhibitor-induced rash. Ketoconazole may reduce the symptoms related to EGFR inhibitor therapy and improve EGFR inhibitor-induced rash.

Location: University of Rochester Medical Center
Study Reference #: UMLT18037

Lead Researcher (Principal Investigator)

Lead Researcher:  Richard Dunne

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search